Stratified analysis based on BM tumor burden (13% as the cutoff) showed that there were no differences in the incidence of severe infections between patients who used G-CSF and those did not in both low- and high-BM tumor burden groups (P = 0.695 and 0.157, respectively) (Table 2).There were no infection-related deaths in this study. Here, CSF3 is linked to infection.